WAZZI-500 contains Azithromycin 500 mg, providing effective antibacterial therapy for selected susceptible infections. A strong and versatile PCD Pharma Antibiotic offering.
Selected bacterial infections.
Yes, unless the physician changes the treatment.
Follow the prescribed regimen and do not self-medicate. Inform the doctor about liver disease, QT prolongation or medicines affecting heart rhythm.
Nausea, diarrhea, abdominal discomfort, vomiting and headache may occur. Rare hepatic and cardiac rhythm-related adverse effects are possible.
WAZZI-500: Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, providing antibacterial activity against susceptible organisms.
